Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
A Phase 4, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to Oral Preventative Medications
Category & Conditions: Neurological Diseases and Conditions
Medicine: Nurtec® ODT (Rimegepant)
ClinicalTrials.gov Identifier (NCT): NCT05518123
Protocol ID: C4951012 (BHV3000-407)
Report Type: Final
Language: English
Open Plain Language Summary Result:
Click here